RUNX1通过mTOR通路促进非小细胞肺癌细胞系的增殖和迁移
Huan Ma1,2, Siyu Jiang1, Yinan Yuan1
1Department of Pathology, Basic Medicine College, China Medical University, Shenyang, China.
概括
在非小细胞肺癌 (NSCLC) 中,RUNX1的表达很高,通过mTOR途径促进瘤生长和转移. 针对RUNX1为NSCLC患者提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- RUNX1是一种转录因子,参与细胞生长和瘤发育.
- 在非小细胞肺癌 (NSCLC) 中RUNX1的特定作用和机制尚不清楚.
研究的目的:
- 研究RUNX1在NSCLC中的作用和分子机制.
- 评估RUNX1作为NSCLC的潜在治疗点.
主要方法:
- 使用TCGA,GEO,GEPIA和Kaplan-Meier数据库进行生物信息分析.
- 110个NSCLC组织样本的免疫组织化学染色.
- 在体外细胞增殖和迁移测试.
- 西部斑点分析和mTOR途径抑制与拉帕米辛.
主要成果:
- 与正常组织相比,RUNX1在NSCLC组织中表达高.
- 高RUNX1表达与预后不佳,淋巴结转移和高级TNM阶段相关.
- 通过调节mTOR通路,RUNX1过度表达促进了NSCLC细胞的增殖和迁移.
- 通过mTOR通路,RUNX1影响了PD-L1的表达.
结论:
- 在NSCLC的进展中,RUNX1起着重要的作用.
- RUNX1通过mTOR途径调节NSCLC细胞功能,影响PD-L1的表达.
- RUNX1代表了NSCLC的一个有前途的治疗点.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.3K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
